Diagnose Early

For Cancer, Infectious Diseases,  and Neurological Diseases

About Diagnose Early

Founded by a Nobel Prize-winning team including a Stanford M.D./Ph.D., a Nobel Laureate, and a Harvard Business School/UW Madison Engineer who came together through a shared vision of improving patient outcomes with innovative and early, non-invasive detection of biomarkers for cancer, neurological diseases, and infectious diseases.

At Diagnose Early, our mission is to reduce human suffering and provide valuable healthcare insights by performing non-invasive rapid testing of patients for high demand, mass-market diseases.  Our customers are large scale healthcare providers.  We leverage cutting edge technology for our customers to support difficult-to-resolve healthcare conditions on a massive scale. We produce massive volumes of data that support the development of breakthrough interventional therapeutics for the diseases we diagnose.     

Meet the Team

Chris Wheeler
Founder & CEO

Stacey Niermann
Corporate Development

Dr. Karl-Magnus Larsson, Ph.D.
Chief Science Officer

Dr. Al Brooke – Clinical Affairs

Dr. Albert Brooks - M.D.
Clinical Affairs

Dr. Christopher Lock, M.D., Ph.D.,

Alyson B. Mullen Regulatory Affairs

Alyson B. Mullen
Regulatory Affairs

Proud Member

Of The Stanford University



39655 Eureka Drive
Newark, CA 94560
(415) 595-4911


Monday-Friday: 9am to 7pm

Saturday: 9am to 4pm

Sunday: Closed